Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Heidelberg
NRG Oncology
EBG MedAustron GmbH
EBG MedAustron GmbH
Mayo Clinic
M.D. Anderson Cancer Center
University Hospital Heidelberg
M.D. Anderson Cancer Center
Emory University
Emory University
Mayo Clinic
NRG Oncology
NRG Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Mayo Clinic
Massachusetts General Hospital
Emory University
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Proton Collaborative Group
Emory University
NRG Oncology
Mayo Clinic
Loma Linda University
Radiation Therapy Oncology Group
Technische Universität Dresden
Mayo Clinic
Massachusetts General Hospital
M.D. Anderson Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Heidelberg University
Loma Linda University
Massachusetts General Hospital
Loma Linda University
Technische Universität Dresden
Shanghai Proton and Heavy Ion Center
Odense University Hospital
Fudan University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai Proton and Heavy Ion Center
Shanghai Proton and Heavy Ion Center
Massachusetts General Hospital
Hospices Civils de Lyon
Loma Linda University
The First Affiliated Hospital with Nanjing Medical University
Massachusetts General Hospital
Shanghai Proton and Heavy Ion Center